Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Conditions

Prostatic Neoplasms 21 Carcinoma, Non-Small-Cell Lung 21 Breast Neoplasms 20 Neoplasms 19 Stomach Neoplasms 15 Colorectal Neoplasms 15 Lung Neoplasms 13 Endometrial Neoplasms 13 Pancreatic Neoplasms 11 Leukemia, Myeloid, Acute 10 Colonic Neoplasms 9 Carcinoma, Hepatocellular 9 Oropharyngeal Neoplasms 6 Neoplasm Metastasis 6 Multiple Myeloma 6 Melanoma 6 Lymphoma, Large B-Cell, Diffuse 6 Esophageal Neoplasms 6 Squamous Cell Carcinoma of Head and Neck 5 Sarcoma 5 Rectal Neoplasms 5 Mouth Neoplasms 5 Leukemia, Lymphocytic, Chronic, B-Cell 5 Head and Neck Neoplasms 5 Uterine Cervical Neoplasms 4 Recurrence 4 Precursor Cell Lymphoblastic Leukemia-Lymphoma 4 Lymphoma, Mantle-Cell 4 Leukemia, Myelomonocytic, Acute 4 Leukemia, Monocytic, Acute 4

Interventions

Megestrol Acetate 9 Exercise 6 Standard of Care 4 Blood Specimen Collection 4 Olanzapine 3 Ibuprofen 3 dermcidin 2 anamorelin 2 Resistance Training 2 Physical Therapy Modalities 2 Nutrition Assessment 2 Mirtazapine 2 Melatonin 2 Infliximab 2 Enteral Nutrition 2 Dietary Supplements 2 Diet Therapy 2 Cyproheptadine 2 testosterone enanthate 1 telotristat ethyl 1 remune 1 ostarine 1 olanzapine-fluoxetine combination 1 nabiximols 1 nabilone 1 irinotecan sucrosofate 1 fucoidan 1 clazakizumab 1 bermekimab 1 alkaloid GB18 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Cachexia × Observation × Clear all

NCT03789136 2021-06-29

COMUNEX

Wageningen University

Cachexia, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡